Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1Terminated 1Available 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Leukemia, Myeloid, Acute 41Myelodysplastic Syndromes 13Leukemia, Lymphocytic, Chronic, B-Cell 12Neoplasms 9Leukemia, Myelomonocytic, Chronic 8Leukemia 8Recurrence 7Lymphoma, Non-Hodgkin 7Lymphoma, Large B-Cell, Diffuse 7Lymphoma, Follicular 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Lymphoma, Mantle-Cell 5Lymphoma, B-Cell, Marginal Zone 4Hematologic Neoplasms 4Breast Neoplasms 4Neoplasm Metastasis 3Multiple Myeloma 3Lymphoma, B-Cell 3Leukemia, Myeloid 3Myeloproliferative Disorders 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Leukemia, Biphenotypic, Acute 2Blast Crisis 2Thrombocytosis 1Small Cell Lung Carcinoma 1Sarcoma 1Prostatic Neoplasms 1Primary Myelofibrosis 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1

Interventions

Dexamethasone 3Calcium Dobesilate 3Melphalan 2venetoclax 1pomalidomide 1Thalidomide 1Surveys and Questionnaires 1Etoposide 1Doxorubicin 1Cyclophosphamide 1Cisplatin 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Amyloidosis × venetoclax × Clear all
NCT03000660 2020-08-21

Trial of Venetoclax (ABT-199) and Dexamethasone for Relapsed or Refractory Systemic AL Amyloidosis

Tufts Medical Center

Phase 1 Terminated
3 enrolled
Plasma cell

Immunoglobulin Light-chain Amyloidosis, Amyloidosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡